On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology ...
TDK Corporation (TSE: 6762) announced today that its corporate venture-capital subsidiary, TDK Ventures, Inc., is investing ...